@article{JTD26629,
author = {Eric H. Bernicker and Timothy Craig Allen and Phillip T. Cagle},
title = {Update on emerging biomarkers in lung cancer},
journal = {Journal of Thoracic Disease},
volume = {11},
number = {Suppl 1},
year = {2019},
keywords = {},
abstract = {There has been considerable progress made in identifying oncogenic driver mutations in advanced lung cancer. The recognition that lung cancer is actually an umbrella classification that is comprised of multiple molecular subgroups has had a profound impact on how medical oncologists make treatment decisions. These mutations are clinically important as available targeted therapies can achieve significant responses and prolonged disease control. This review will summarize the current guidelines for biomarker testing and available therapeutic agents.},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/26629}
}